Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

NCT02027753 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: INSULIN GLARGINE
DRUG: Metformin
DRUG: DPP-4 inhibitor
DRUG: Sulphonylurea

Sponsor

Sanofi